| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-26065-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18800-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06408-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-05814-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20217-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06409-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90336-500ug | |||
![Western Blot: MERS-CoV Spike Protein Antibody (12) - Azide and BSA Free [NBP3-26065] - NBP3-26065 at 1:5000 dilution. Lane A: MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297) 40ng. Lane B: MERS-CoV Spike/S1 Protein (S1 Subunit, aa 1-725) 40ng Lane C: MERS-CoV Spike/S2 Protein (S2 Subunit, aa 726-1296) 40ng Lane D: MERS-CoV Spike/RBD Protein fragment (RBD, aa 367-606) 40ng Secondary Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-26065_mouse-mers-cov-spike-protein-mab-12-azide-and-bsa-free-136202422345028.png "Western Blot: MERS-CoV Spike Protein Antibody (12) - Azide and BSA Free [NBP3-26065] - NBP3-26065 at 1:5000 dilution. Lane A: MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297) 40ng. Lane B: MERS-CoV Spike/S1 Protein (S1 Subunit, aa 1-725) 40ng Lane C: MERS-CoV Spike/S2 Protein (S2 Subunit, aa 726-1296) 40ng Lane D: MERS-CoV Spike/RBD Protein fragment (RBD, aa 367-606) 40ng Secondary Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.")
![Western Blot: MERS-CoV Spike Protein Antibody [NBP3-18800] - Each lane was blotted with NBP3-18800 at 1:2000 dilution, Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution as a secondary. Developed using the ECL technique under reducing conditions. Lane A: MERS-CoV Spike Protein (S2 Subunit, aa 726-1296) 5ng. Lane B: MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297) 5ng.](http://images.novusbio.com/fullsize/MERS-CoV Spike Protein Antibody-Western Blot-NBP3-18800-img0001.jpg "Western Blot: MERS-CoV Spike Protein Antibody [NBP3-18800] - Each lane was blotted with NBP3-18800 at 1:2000 dilution, Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution as a secondary. Developed using the ECL technique under reducing conditions. Lane A: MERS-CoV Spike Protein (S2 Subunit, aa 726-1296) 5ng. Lane B: MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297) 5ng.")
![Western Blot: MERS-CoV Spike Protein Antibody [NBP3-06408] - NBP3-06408 at 1:1000 dilution. Sample:MERS-CoV (NCoV / Novel coronavirus) (NCoV / Novel coronavirus) Spike protein (ECD, aa 1-1297) Lane A: 5ng Lane B: 2ng Lane C: 1ng Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-06408_rabbit-polyclonal-mers-cov-spike-protein-antibody-235202511354112.png "Western Blot: MERS-CoV Spike Protein Antibody [NBP3-06408] - NBP3-06408 at 1:1000 dilution. Sample:MERS-CoV (NCoV / Novel coronavirus) (NCoV / Novel coronavirus) Spike protein (ECD, aa 1-1297) Lane A: 5ng Lane B: 2ng Lane C: 1ng Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.")
![Western Blot: MERS-CoV Spike Protein Antibody [NBP3-05814] - NBP3-05814 at 1:500 dilution. Sample:Novel coronavirus (HCoV-EMC/2012) Spike protein (ECD, aa 1-1297) Lane A: 500ng Lane B: 200ng Lane C: 100ng Secondary Goat Anti- Rabbit IgG (H+L)/HRP at 0.4ug/mldilution. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-05814_rabbit-polyclonal-mers-cov-spike-protein-antibody-235202521525047.png "Western Blot: MERS-CoV Spike Protein Antibody [NBP3-05814] - NBP3-05814 at 1:500 dilution. Sample:Novel coronavirus (HCoV-EMC/2012) Spike protein (ECD, aa 1-1297) Lane A: 500ng Lane B: 200ng Lane C: 100ng Secondary Goat Anti- Rabbit IgG (H+L)/HRP at 0.4ug/mldilution. Performed under reducing conditions.")
![Western Blot: MERS-CoV Spike Protein Antibody - N-terminal [NBP3-20217] - NBP3-20217 at 1:2000 dilition. Lane A: MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297)(100ng) Lane B: MERS-CoV Spike Protein (S1 Subunit, aa 1-725)(20ng) Lane C: MERS-CoV Spike Protein (S1 Subunit, aa 1-725)(20ng) Lane D: MERS-CoV Spike Protein (S2 Subunit, aa 726-1296)(500ng) Secondary Goat Anti-Rabbit IgG (H+L) [HRP] at 1:10000 dilution. Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-20217_rabbit-mers-cov-spike-protein-pab-n-terminal-136202422345010.png "Western Blot: MERS-CoV Spike Protein Antibody - N-terminal [NBP3-20217] - NBP3-20217 at 1:2000 dilition. Lane A: MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297)(100ng) Lane B: MERS-CoV Spike Protein (S1 Subunit, aa 1-725)(20ng) Lane C: MERS-CoV Spike Protein (S1 Subunit, aa 1-725)(20ng) Lane D: MERS-CoV Spike Protein (S2 Subunit, aa 726-1296)(500ng) Secondary Goat Anti-Rabbit IgG (H+L) [HRP] at 1:10000 dilution. Developed using the ECL technique. Performed under reducing conditions.")